-
1
-
-
0012539580
-
-
Centers for Disease Control and Prevention Last accessed Oct. 29, 2007
-
Centers for Disease Control and Prevention. Sexually transmitted diseases: treatment guidelines 2002. http://www.cdc.gov/STD/treatment/5-2002TG.htm Last accessed Oct. 29, 2007
-
Sexually transmitted diseases: treatment guidelines 2002
-
-
-
2
-
-
0020317997
-
Genital candidiasis
-
Odds F.C. Genital candidiasis. Clin Exp Dermatol 7 (1982) 345-354
-
(1982)
Clin Exp Dermatol
, vol.7
, pp. 345-354
-
-
Odds, F.C.1
-
3
-
-
7944238320
-
Clinical and mycological efficacy of single-day oral treatment with itraconazole (400 mg) in acute vulvovaginal candidosis
-
Urunsak M., Ilkit M., Evruke C., and Urunsak I. Clinical and mycological efficacy of single-day oral treatment with itraconazole (400 mg) in acute vulvovaginal candidosis. Mycoses 47 (2004) 422-427
-
(2004)
Mycoses
, vol.47
, pp. 422-427
-
-
Urunsak, M.1
Ilkit, M.2
Evruke, C.3
Urunsak, I.4
-
4
-
-
34249895255
-
Vulvovaginal candidiasis
-
Sobel J.D. Vulvovaginal candidiasis. Lancet 369 (2007) 1961-1971
-
(2007)
Lancet
, vol.369
, pp. 1961-1971
-
-
Sobel, J.D.1
-
5
-
-
85089921167
-
-
Watson MC, Grimshaw JM, Bond CM, Mollison J, Ludbrook A. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated candidiasis (thrush) [review]. Cochrane Database Syst Rev 2001, Issue 3. Art No:CD002845.
-
-
-
-
6
-
-
24144435977
-
Making sense of itraconazole pharmacokinetics
-
Prentice A.G., and Glasmacher A. Making sense of itraconazole pharmacokinetics. JAC 56 suppl (2005) i17-i22
-
(2005)
JAC
, vol.56
, Issue.SUPPL
-
-
Prentice, A.G.1
Glasmacher, A.2
-
7
-
-
32644433583
-
Fluconazole for the treatment of invasive candidiasis: where do we stand after 15 years?
-
Charlier C., Hart E., Lefort A., et al. Fluconazole for the treatment of invasive candidiasis: where do we stand after 15 years?. J Antimicrob Chemother 57 (2006) 384-410
-
(2006)
J Antimicrob Chemother
, vol.57
, pp. 384-410
-
-
Charlier, C.1
Hart, E.2
Lefort, A.3
-
8
-
-
38349189697
-
-
Health Services/Technology Assessment Text and the National Library of Medicine Last accessed Oct. 29, 2007
-
Health Services/Technology Assessment Text and the National Library of Medicine. Criteria for grading quality of randomized controlled trials: the Jadad Score. http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat3.section.3039 Last accessed Oct. 29, 2007
-
Criteria for grading quality of randomized controlled trials: the Jadad Score
-
-
-
9
-
-
0032173612
-
A single blind comparative study between itraconazole and fluconazole in the one-day treatment of vulvo-vaginal candidiasis
-
Singson-alday A.P., and Ortega A.R. A single blind comparative study between itraconazole and fluconazole in the one-day treatment of vulvo-vaginal candidiasis. Phillip J Obstet Gynecol 22 (1998) 119-121
-
(1998)
Phillip J Obstet Gynecol
, vol.22
, pp. 119-121
-
-
Singson-alday, A.P.1
Ortega, A.R.2
-
10
-
-
33749318858
-
Terbinafine versus itraconazole and fluconazole in the treatment of vulvovaginal candidiasis
-
Ferahbas A., Koc A.N., Uksal U., Aygen E., Mistik S., and Yildiz S. Terbinafine versus itraconazole and fluconazole in the treatment of vulvovaginal candidiasis. Am J Ther 13 (2006) 332-336
-
(2006)
Am J Ther
, vol.13
, pp. 332-336
-
-
Ferahbas, A.1
Koc, A.N.2
Uksal, U.3
Aygen, E.4
Mistik, S.5
Yildiz, S.6
-
11
-
-
1242288204
-
Correlation of in vitro itraconazole and fluconazole susceptibility with clinical outcome for patients with vulvovaginal candidiasis
-
Costa M., Passos X.S., Miranda A.T.B., Carneiro de Araujo R.S., Paula C.R., and Silva M.R.R. Correlation of in vitro itraconazole and fluconazole susceptibility with clinical outcome for patients with vulvovaginal candidiasis. Mycopathologia 157 (2004) 43-47
-
(2004)
Mycopathologia
, vol.157
, pp. 43-47
-
-
Costa, M.1
Passos, X.S.2
Miranda, A.T.B.3
Carneiro de Araujo, R.S.4
Paula, C.R.5
Silva, M.R.R.6
-
12
-
-
0037428914
-
Fluconazole 150 mg single dose versus itraconazole 200 mg per day for 3 days in the treatment of acute vaginal candidiasis: a double-blind randomized study
-
DePunzio C., Garutti P., Mollica G., Nappi C., Piccoli R., and Genazzani A.R. Fluconazole 150 mg single dose versus itraconazole 200 mg per day for 3 days in the treatment of acute vaginal candidiasis: a double-blind randomized study. Eur J Obstet Gynecol Reprod Biol 106 (2003) 193-197
-
(2003)
Eur J Obstet Gynecol Reprod Biol
, vol.106
, pp. 193-197
-
-
DePunzio, C.1
Garutti, P.2
Mollica, G.3
Nappi, C.4
Piccoli, R.5
Genazzani, A.R.6
-
13
-
-
0031811751
-
Comparative study on the effectiveness of anti-fungal agents in different regimens against vaginal candidiasis
-
Mikamo H., Kawazoe K., Sato Y., Hayasaki Y., and Tamaya T. Comparative study on the effectiveness of anti-fungal agents in different regimens against vaginal candidiasis. Chemotherapy 44 (1998) 364-368
-
(1998)
Chemotherapy
, vol.44
, pp. 364-368
-
-
Mikamo, H.1
Kawazoe, K.2
Sato, Y.3
Hayasaki, Y.4
Tamaya, T.5
-
14
-
-
0028931744
-
Comparison of clotrimazole, fluconazole and itraconazole vaginal candidiasis
-
Woolley P.D., and Higins S.P. Comparison of clotrimazole, fluconazole and itraconazole vaginal candidiasis. Br J Clin Pharmacol 49 (1995) 65-66
-
(1995)
Br J Clin Pharmacol
, vol.49
, pp. 65-66
-
-
Woolley, P.D.1
Higins, S.P.2
-
15
-
-
0026542454
-
Multicenter comparison of one-day oral therapy with fluconazole or itraconazole in vaginal candidiasis
-
Rees T., and Phillips R. Multicenter comparison of one-day oral therapy with fluconazole or itraconazole in vaginal candidiasis. Int J Gynecol Obstet 37 (1992) 33-38
-
(1992)
Int J Gynecol Obstet
, vol.37
, pp. 33-38
-
-
Rees, T.1
Phillips, R.2
-
16
-
-
38349183855
-
-
British National Formulary 45 March 2003, p. 296-8, British Medical Association, Royal Pharmaceutical Society of Great Britain.
-
-
-
|